How molecular advances may improve the diagnosis and management of PTCL patients

Peripheral T-cell lymphomas (PTCL) comprised more than 30 rare heterogeneous entities, representing 10 to 15% of adult non-Hodgkin lymphomas. Although their diagnosis is still mainly based on clinical, pathological, and phenotypic features, molecular studies have allowed for a better understanding o...

Descripción completa

Detalles Bibliográficos
Autores principales: Drieux, Fanny, Lemonnier, François, Gaulard, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328093/
https://www.ncbi.nlm.nih.gov/pubmed/37427095
http://dx.doi.org/10.3389/fonc.2023.1202964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328093/
https://www.ncbi.nlm.nih.gov/pubmed/37427095
http://dx.doi.org/10.3389/fonc.2023.1202964

Ejemplares similares